XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Capital Stock and Earnings Per Share
 9 Months Ended
Nov. 01, 2025
Equity [Abstract]  
Capital Stock and Earnings Per Share Capital Stock and Earnings Per Share
Capital Stock
In February 2025, the Company announced that its Board of Directors had approved a new stock repurchase program that authorizes the repurchase of up to an additional $2.5 billion of TJX common stock from time to time. Under this program, TJX had approximately $1.9 billion available for repurchase as of November 1, 2025.
The following table provides share repurchases, excluding applicable excise tax:
Thirteen Weeks EndedThirty-Nine Weeks Ended
In millionsNovember 1,
2025		November 2,
2024		November 1,
2025		November 2,
2024
Total number of shares repurchased and retired4.2 5.0 13.4 15.4 
Total cost
$594 $574 $1,722 $1,642 
All shares repurchased under the stock repurchase programs have been retired. These expenditures were funded by cash on hand and cash generated from operations.
Earnings Per Share
The following table presents the calculation of basic and diluted earnings per share:
 Thirteen Weeks EndedThirty-Nine Weeks Ended
Amounts in millions, except per share amountsNovember 1,
2025		November 2,
2024		November 1,
2025		November 2,
2024
Basic earnings per share:
Net income
$1,442 $1,297 $3,721 $3,466 
Weighted average common shares outstanding for basic earnings per share calculation
1,112 1,127 1,115 1,130 
Basic earnings per share
$1.30 $1.15 $3.34 $3.07 
Diluted earnings per share:
Net income
$1,442 $1,297 $3,721 $3,466 
Weighted average common shares outstanding for basic earnings per share calculation
1,112 1,127 1,115 1,130 
Assumed exercise/vesting of stock options and awards14 14 14 14 
Weighted average common shares outstanding for diluted earnings per share calculation
1,126 1,141 1,129 1,144 
Diluted earnings per share
$1.28 $1.14 $3.30 $3.03 
Cash dividends declared per share$0.425 $0.375 $1.275 $1.125 
The weighted average common shares for the diluted earnings per share calculation excludes the impact of outstanding stock options if the assumed proceeds per share of the option is in excess of the average price of TJX’s common stock for the related fiscal periods. Such options are excluded because they would have an antidilutive effect. There were 3 million antidilutive options excluded for the thirteen weeks and thirty-nine weeks ended November 1, 2025 and 4 million antidilutive options excluded for the thirteen weeks and thirty-nine weeks ended November 2, 2024.